Stocksigma LogoStocksigma Logo

Alkem Laboratories Reports Q2FY27 Results with 13.8% Revenue Growth

Alkem Laboratories posted consolidated revenue from operations of ₹45,520 million for Q2FY27, up 13.8% YoY, supported by 9.5% growth in India sales to

Alkem Laboratories Reports Q2FY27 Results with 13.8% Revenue Growth

Alkem Laboratories Ltd · Outcome · 12 Nov 2026, 7:24 pm

Alkem Laboratories Reports Q2FY27 Results with 13.8% Revenue Growth Alkem Laboratories posted consolidated revenue from operations of ₹45,520 million for Q2FY27, up 13.8% YoY, supported by 9.5% growth in India sales to ₹30,275 million and a 22.3% rise in international sales to ₹14,540 million. EBITDA increased 11.3% YoY to ₹10,252 million with a 22.5% margin. Reported PAT declined 11.7% YoY to ₹6,753 million due to higher effective tax rates. Net cash reached ₹49,054 million as of 30th Sep'26. Additionally, the company integrated Occlutech following its 55% stake acquisition.

Original exchange filing (PDF)

More announcements from Alkem Laboratories Ltd

All Alkem Laboratories Ltd announcements